Abstract
The science of internal dosimetry is a specialty within the general field of health physics. A working definition of health physics might be “the protection of people and their environment from the harmful effects of radiation while allowing its beneficial applications.” With any application involving the use of ionizing radiation, the risks of its use must be balanced against its benefits. With medical uses of radiation, the benefits are immediately obvious and are directly received by the person exposed to the risk. This makes the balancing process considerably easier than, for example, the use of nuclear power, where a small number of people incur a risk so a broad region can receive a benefit. This balance, however, cannot be evaluated without some quantification of the risks. Internal dosimetry calculations provide estimates of the amount of radiation that is absorbed by different organs or organ systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arnold R, Subramanian G, McAfee J et al. Comparison of 99mTc complexes for renal imaging. J Nucl Med 1975;16:357–367
Atkins H, Cloutier R, Lathrop K et al. MIRD dose estimate report no. 3: radiation absorbed dose estimates for technetium-99m sulfur colloid in various liver conditions. J Nucl Med 1975;16:108A-108B
Atkins H, Robertson J, Croft B et al. MIRD dose estimate report no. 9: radiation absorbed dose estimates for radioxenons in lung imaging. J Nucl Med 1980; 21:459–465
Atkins H, Thomas S, Buddemeyer U, Chervu L. MIRD dose estimate report no. 14: radiation absorbed dose from technetium-99m-labeled red blood cells. J Nucl Med 1990;31:378–380
Bell E, Subramanian G, Blair R, McAfee J. Bone scanning in pediatrics. In: Pediatric Nuclear Medicine. Philadelphia: Saunders, 1974:84–94
Berman M, Braverman L, Burke J et al. MIRD dose estimate report no. 5: radiation absorbed dose estimates for I-123, I-124,I-125,I-126,1–130,1–131, and 1–132 as sodium iodide. J Nucl Med 1975; 16: 857–860
Blau M, Wicks R, Thomas S, Lathrop K. MIRD dose estimate report no. 10: radiation absorbed dose estimates for albumin microspheres labeled with tech-netium-99m. J Nucl Med 1982;23:915–917
Blaufox M, Gruskin B, Sandler P, et al. Detection of ureteral-vesical reflux in children with 99mTc -pertechnetate. J Nucl Med 1970;11:622–623
Castle V, Shulkin B, Coates G, Andrew M. The use of indium-111 oxine platelet scintigraphy and survival studies in pediatric patients with thrombocytopenia. J NuclMed 1989;30:1819–1824
Cloutier R, Watson E, Hayes R et al. MIRD dose estimate report no. 2: radiation absorbed dose estimates for gallium-66-, gallium-67-, gallium-68- and galliums-citrate. J Nucl Med 1973;14:755–756
Coates G, O’Brodovich H. Extrapulmonary radioactivity in lung permeability measurements. J Nucl Med 1987;28:903–906
Coenegracht J, Oei T, van Breda Vriesman R. The influence of bilirubin, alcohol, and certain drugs on the kinetics of 99mTc -diethyl IDA (EHIDA) in humans. Eur J Nucl Med 1983;8:140–144
Cristy M, Eckerman K. Specific Absorbed Fractions of Energy at Various Ages from Internal Photons Sources. ORNL/TM-8381 V1-V7. Oak Ridge, TN: Oak Ridge National Laboratory, 1987
Datz F. The role of radionuclide studies in esophageal disease. J Nucl Med 1984;25:1040–1045
Dyrbye M, Brendstrup L, Carlsen N. Micturition cystourethrography using x-ray or scintigraphy in children with reflux. Eur J Nucl Med 1983;8:A14
Ellett W, Humes R. MIRD pamphlet no. 8: absorbed fractions for small volumes containing photon-emitting radioactivity. J Nucl Med 1972;7(suppl 6)
Erlich C, Papanicolaou N, Treves T et al. Splenic scintigraphy using Tc-99m-labeled heat-denatured red blood cells in pediatric patients: concise communication. J Nucl Med 1982;23:209–213
Evans I, Hambleton G, Mann N, Brown J. The distribution of lung damage in children with cystic fibrosis and its relationship to colonization with Pseudomonas aeruginosa. Eur J Nucl Med 1987;12: 620–622
Frietas J, Swanson D, Gross M, Sisson J. Iodine-131: optimal therapy for hyperthyroidism in children and adolescents? J Nucl Med 1979;20:847–850
Gainey M, Siegel J, Smergel E, Jara B. Indium-111-labeled white blood cells: dosimetry in children. J NuclMed 1988;29:689–694
Gelbard A, Benua R, Laughlin J et al. Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate. J Nucl Med 1979;20:782–784
Gelfand M, Silberstein E, Cox J. Diagnosis of Meckel’s diverticulum by scintigraphy: clinical and pathological correlation. J Nucl Med 1976; 17:553
Goodwin D, Finston R, Smith SI. The distribution and dosimetry of In-111l labeled leukocytes and platelets in humans. In: Proceedings, Third International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, 1981
Guillet J, Basse-Cathalinat B, Christophe E et al. Routine studies of swallowed radionuclide transit in paediatrics: experience with 400 patients. Eur J Nucl Med 1984;9:86–90
Gupta S et al. Testicular-scrotal content of 201T1 and 67Ga after intravenous administration. Int J Nucl Med Biol 1981;8:211–213
Ham H, Piepsz A, Georges B et al. Quantitation of esophageal transit by means of 81mKr. Eur J Nucl Med 1984;9:362–365
Handmaker H, O’Mara R. Gallium imaging in pediatrics. JNuclMed 1975;16:533
Harcke H. Jr. Bone imaging in infants and children: a review. J Nucl Med 1978;19:324–329
Hattner R, Maltz H, Holliday M. Differentiation of reversible ischemia from end-stage renal failure in nephrotic children with 131I-hippurate dynamic scintigraphy. J Nucl Med 1977; 18:438–440
Hogg J, Williams J, Richardson J et al. Age as a factor in the distribution of lower airway conductance and in the pathologic anatomy of obstructive lung disease. N Engl J Med 1970;282:1283–1287
International Commission of Radiation Units and Measurements, Radiation Quantities and Units, ICRU 33. International Commission on Radiation Units and Measurements, 1980 Bethesda, MD.
International Commission on Radiological Protection. Limits for Intakes of Radionuclides by Workers. ICRP Publication 30. New York: Pergamon Press, 1979
International Commission on Radiological Protection. Protection of the Patient in Nuclear Medicine. ICRP Publication 52. New York: Pergamon Press, 1987
International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53. New York: Pergamon Press, 1988
International Commission on Radiological Protection. Radionuclide Transformations: Energy and Intensity of Emissions. New York: Pergamon Press, 1983
International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. ICRP Publication 26. New York: Pergamon Press, 1977
International Commission on Radiological Protection. Report of the Task Group on Reference Man. ICRP Publication 23. New York: Pergamon Press, 1975
Jacobsson L, Mattsson S, Johansson L et al. Biokinetics and dosimetry of 131I-metaiodobenzylguanidine (MIBG). In: Proceedings, Fifth International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, 1985
Jaw T, Wu C-C, Ho Y-H et al. Diagnosis of obstructive jaundice in infants: Tc-99m DISIDAin duodenal juice. J Nucl Med 1984;25:360–363
Jeandot R, Lambert B, Brendel A et al. Lung ventilation and perfusion scintigraphy in the follow up of repaired congenital diaphragmatic hernia. Eur J Nucl Med 1989;15:591–596
Kilburn E, Gilday D, Ash J. Meckel’s diverticula-multiple view imaging. J Nucl Med 1976;25: 360–363
Knapp W, Helus F, Ostertag H et al. N-13 L-gluta-mate uptake in malignancy: its relationship to blood flow. J Nucl Med 1982;25:989–997
Krahwinklel W, Herzog H, Feinendegen L. Pharmacokinetics of thallium-201 in normal individuals after routine myocardial scintigraphy. J Nucl Med 1988;29:1582–1586
Lashford L, Moyes J, Ott R et al. The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma. Eur J Nucl Med 1988; 13:574–577
Lathrop K, Atkins H, Berman M et al. MIRD dose estimate report no. 8: radiation absorbed dose estimates for technetium-99m as sodium pertechnetate. J Nucl Med 1976;17:74–77
Lee W, Mpanias P, Wimmer R et al. Use of 1–123 in early radioiodide uptake and its suppression in children and adolescents with hyperthyroidism. J Nucl Med 1978;19:985–993
Lee PS, Gerrity TR, Hass FJ, Lourenco RV. A model for tracheobronchial clearance of inhaled particles in man and comparison with data. IEEE Trans Biomed Eng. 1979;26(ll):624–630
Lindmo T, Skretting A, Nakken K. An examination of different mathematical models for renal function as measured by 131I-hippuran renography. Med Phys 1974;1:193–197
Loevinger R, Budinger T, Watson E. MIRD Primer for Absorbed Dose Calculations. New York: Society of Nuclear Medicine, 1988
Marcus C, Kuperus J. Pediatric renal iodine-123 orthoiodohippurate dosimetry. J Nucl Med 1985; 26:1211–1214
Marcus C, Stabin M, Watson E. Pediatric radiation dose from [mIn]leukocytes. J Nucl Med 1986; 27:1220–1221
Marcus C, Stabin M, Watson E et al. Dosimetry of leukocytes labeled with Tc-99m-albumin colloid. Nucl Med Commun 1988;9:249–254
Miller J. Technetium-99m-labeled red blood cells in the evaluation of hemangiomas of the liver in infants and children. J Nucl Med 1987;28:1412–1418
Moyes J, Babich J, Carter R et al. Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology. J Nucl Med 1989;30:474–480
Papanicolaou N, Treves S. Pulmonary scintigraphy in pediatrics. Semin Nucl Med 1980;10:259–285
Piepsz A, Ham H, Struyven J et al. Simultaneous determination of the separate glomerular filtration rate and the intrarenal transit times by means of the Tc-99m-DTPA complex: validation and results in pediatric urology. J Nucl Med 1978;19:699
Poston J. Application of the effective dose equivalent to nuclear medicine patients. J Nucl Med 1993; 34:714–716
Poston J, Aissi A, Hui T, Jimba B. A preliminary model of the circulating blood for use in radiation dose calculations. In Schlafke-Stelson A, Watson E (eds): Fourth International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, 1985: 574–586
Powell G, Schuchard R, Reft C, Harper P. Radiation absorbed dose to tracheal mucosa from inhaled oxygen-15-labeled carbon dioxide. Ann Neurol 1984; 15:S107-S109
Powsner E, Raeside D. Diagnostic Nuclear Medicine. Orlando, FL: Grune & Stratton, 1971:184
Prince J, Zu’bi S, Haag B. Thyroid imaging with iodine-125 and technetium-99m. Eur J Nucl Med 1979;4:37–41
Reiman R, Benua R, Gelbard A et al. Imaging of brain tumors after administration of 1-(N-13) glutamate: concise communication. J Nucl Med 1982; 23:682–687
Rosen P, Kuruc A, Treves S. The determination of relative renal function in a pediatric population using Tc-99m DTPA and Tc-99m DMSA. J Nucl Med 1985;26(5):P10
Sinzinger H, Schroth B, Silhan I et al. Experience with radioisotopic vesico-ureteral reflux measurements in 250 children. Eur J Nucl Med 1983;8 (5):A15.
Soundy R, Tyrrell D, Pickett R, Stabin M. The radiation dosimetry of 99mTc -exametazime. Nucl Med Commun 1990;11:791–799
Stabin M, Hach A. Radiation dosimetry and safety. In Gilday D, Hahn K (eds): Paediatrics. Stuttgart: Gustav Fischer Verlag, 1994 (in press)
Stabin M, Taylor A Jr, Conway J. Radiation dosimetry for Tc-99m MAG-3 in adults and children. In: Proceedings, Fifth International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, 1992
Stabin M, Taylor A Jr, Eshima D, Wooten W. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131 OIH based on human biodistribution studies. J Nucl Med 1992;33:33–40
Thakur M, Seifert C, Madsen M et al. Neutrophil labeling: problems and pitfalls. Semin Nucl Med 1984;14:107–117
Thomas S, Atkins H, McAfee J et al. MIRD dose estimate report no. 12: radiation absorbed dose for technetium-99m diethylenetriaminepentaacetic acid. J Nucl Med 1984;25:503–505
Vestergren E, Jacobsson L, Mattsson S et al. Biokinetics and dosimetry of Tc-99m HMPAO in children. In: Proceedings, Fifth International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, 1992
Weber D, Eckerman K, Dillman LT, Ryman J.
MIRD: Radionuclide Data and Decay Schemes. New York: Society of Nuclear Medicine, 1989
Weber D, Makler PT Jr, Watson E et al. MIRD dose estimate report no. 13: radiation absorbed dose from technetium-99m-labeled bone imaging agents. J Nucl Med 1989;30:1117–1122
Weiblen B, Forstrom L, McCullough J. Studies of the kinetics of indium-lll-labeled granulocytes. J Lab Clin Med 1979;94:246–255
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stabin, M.G. (1995). Internal Dosimetry in Pediatric Nuclear Medicine. In: Treves, S.T. (eds) Pediatric Nuclear Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4205-3_26
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4205-3_26
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-4207-7
Online ISBN: 978-1-4757-4205-3
eBook Packages: Springer Book Archive